Skip to main content

Advertisement

Log in

HIV and HPV as Fatal Partners

  • Uterine Fibroids (I Meinhold-Heerlein, Section Editor)
  • Published:
Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Human papillomavirus (HPV) infection is the commonest sexually transmitted infection globally. Many other types of sexually transmitted infections have been considered as co-factors for HPV infection, ranging from Neisseria gonorrhoeae to Chlamydia trachomatis to herpes simplex 2, to name a few. HPV infection, persistent infection with high-risk types, infection with multiple types as well as cervical cancer and its precursors are known to be more prevalent in human immunodeficiency virus (HIV)-infected women. Whether HPV infection stimulates transmission of HIV is still controversial but if this is true, HPV vaccination to prevent HPV infection, particularly with types 16 and 18, may have a significant public health impact. HPV vaccination has been shown to be highly effective in preventing disease caused by its target types, e.g. 16/18 (bivalent vaccine) and 16/18/6/11 (quadrivalent) and appear to be as safe and immunogenic in HIV-infected and HIV-uninfected individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607–15. His article gives a global view of cancer and explains the methodology used by Globocan to analyse the data.

    Article  PubMed  Google Scholar 

  2. Munoz N, Castellsague X, de Gonzalez B, Gissman L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24S3:S3/1–S3/10.

    Google Scholar 

  3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.

    Article  CAS  PubMed  Google Scholar 

  4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Keertie V, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med. 2003;348:518–27. This was the first article to classify HPV Into high and low risk types and is widely quoted.

    Article  Google Scholar 

  5. de Sanjose S, Quint W, Alemany L, Geraets DT, Klaustermeier J, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide stidy. Lancet Oncol. 2010;11:1048–56.

    Article  PubMed  Google Scholar 

  6. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia and Central America: a population based study. Lancet Oncol. 2010;11:165–73.

    Article  PubMed  Google Scholar 

  7. Gondos A, Brenner H, Wabinga H, Parking DM. Cancer survival in Kampala, Uganda. Br J Cancer. 2005;92(9):1808–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. www.unaids.org/AIDSinfo—accessed May 1st, 2015

  9. Harris TG, Burk RB, Palefsky JM, Massed LS, Bang YJ, Anastos K, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts and human papillomavirus test results. JAMA. 2005;293:1471–6.

    Article  CAS  PubMed  Google Scholar 

  10. Singh D, Anastos K, Hoover D, Burk R, Shi Q, Ngendahayo L, et al. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis. 2009;199(12):1851–61. One of the original articles showing the high incidence of HPV in HIV infected women with a control group.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Denny L, Boa R, Williamson A-L, Allan B, Hardie D, Ress S, et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1 infected women.

  12. McDonald AC, Tergas AI, Kuhn L, Denny L, Wright Jr TC. Distribution of human papillomavirus genotypes among HIV-positive and HIV—negative women in Cape Town, South Africa. Front Oncol. 2014;4:48. doi:10.3389/fonc.2014.00048.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Clifford GM, Concalves MA, Franceschi S. HPV, HIV study group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006;20(18):2337–44.

    Article  PubMed  Google Scholar 

  14. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014;314:1389–98.

    Article  Google Scholar 

  15. Schneider E, Whitmore S, Glynn KM, Dominquez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents and children <18 months and for HIV infection and AIDS among children aged 18 months to, 13 years—United States, 2008. MMWR Recomm Rep. 2008;57(RR-19):1–12.

    PubMed  Google Scholar 

  16. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581)(6):59–67.

    Article  Google Scholar 

  17. Shiels MS, Pfeiffer RM, Gail MH, Iren-Hall H, Li J, Chaturvedi AK et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011;103:753–62.

  18. Naucler P, da Costa FM, da Costa JL, Ljungberg O, Bugalho A and Dillner J. Human papillomavirus type-specific risk of cervical cancer in a population with a high human immunodeficiency virus prevalence: case control study. J Gen Virology 2011;92:2784–91.

  19. Lissouba P, Van de Perre P, Auvert B. Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2013;89:350–6. Useful review of the relationship between HPV and HIV.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Smith-McCune KK, Shiboski S, Chirenje MZ, Magure T, Tuveson J, Ma Y, et al. Type specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One. 2010;5(4):e100940.

    Article  Google Scholar 

  21. Smith JS, Moses S, Hudgens MG, Parker CB, Kawango A, Maclean I, et al. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis. 2010;201(11):1677–85.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Rositch AF, Gravitt PE, Smith JS. Growing evidence that HPV infection is associated with an increase in HIV acquisition: exploring the issue of HPV vaccination. Sex Trans Infect. 2013;89(5):357.

    Article  Google Scholar 

  23. Denny L, Hendricks B, Gordon C, Thomas F, Hezareh M, Dobbelaere K, et al. Safety and immunogenicity if the HPV—16/18 ASO4 adjuvanted vaccine in HIV-positive women in South Africa: a partially blind randomised placebo-controlled trial. Vaccine. 2013;31(48):5745–53.

    Article  CAS  PubMed  Google Scholar 

  24. Rainone V, Glacomet V, Penagini F, Fabiano V, Calascibetta F, Mameli C, et al. Human papillomavirus vaccination induces strong virus specific cell-mediated immune responses in HIV-infected adolescents and young adults. AIDS. 2015;29:739–43.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Lynette Denny declares personal fees from Merck, GlaxosmithKline, and Roche for appearances on speaker’s forums.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lynette Denny.

Additional information

This article is part of the Topical Collection on Uterine Fibroids

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Denny, L. HIV and HPV as Fatal Partners. Curr Obstet Gynecol Rep 4, 143–148 (2015). https://doi.org/10.1007/s13669-015-0122-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-015-0122-2

Keywords

Navigation